|
Subotyalov M.A.
Development of ideas about urolithiasis
|
№3 / 2023
|
|
Nasirov A.A., Khotamov Kh.N., Baiakhmedov F.F., Khoshimov T.R.
The choice of surgical tactics for calculous anuria in infants
|
№3 / 2023
|
|
Vtorenko V.I., Trushkin R.N., Medvedev P.E., Vinogradov V.E., Isaev T.K., Sokolov S.A., Bondarenko S.A., Kolesnikov N.O., Ivanov K.V.
The use of bilateral total transarterial renal embolization for the combined treatment of patients with symptomatic autosomal dominant polycystic kidney disease and end-stage renal disease
|
№3 / 2023
|
|
Pyatchenkov M.O., Sherbakov E.V., Trandidna A.E., Belskykh A.N.
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure
|
№3 / 2023
|
|
Moiseev S.V., Shchulkin A.V., Abalenikhina Yu.V., Mylnikov P.Yu., Yakusheva E.N., Khmelevsky M.S., Matsiyak M.V.
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers
|
№3 / 2023
|
|
Yakovenko A.A., Lavrishcheva Yu.V., Rumyantsev A.Sh., Belskikh A.N.
The significance of TNF-α in the pathogenesis of protein-energy malnutrition in patients on program hemodialysis
|
№3 / 2023
|
|
Sokolova A.V., Dragunov D.O., Arutyunov G.P.
The prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease
|
№3 / 2023
|
|
Shilov E.M., Shilova M.M., Rumyantseva E.I., Batyushin M.M., Bevzenko A.Yu., Belskikh A.N., Veselkova N.V., Yesayan A.M., Ivliev S.V., Kotenko O.N., Petrova N.Yu., Statsenko M.E., Stolyar A.G.
Nephrological service of the Russian Federation 2022: post-covid period
|
№3 / 2023
|
|
Murkamilov I.T., Fomin V.V., Sabirov I.S., Satkynalieva Z.T., Yusupov F.A.
Thrombosis and embolism in patients with chronic kidney disease
|
№2 / 2023
|
|
Litvinov A.S., Gasanov M.Z., Kuznetsova Yu.V., Gergia S.R., Shevchenko S.V.
Mechanisms of albumin loss against the background of the use of modern methods of renal replacement therapy
|
№2 / 2023
|
|
Vorotylov A.A., Mikhailova Z.D.
Features of kidney damage in metabolic syndrome
|
№2 / 2023
|
|
Frolova N.F., Varyasin V.V., Volgina G.V., Sysoeva I.L., Mudarisov R.R., Usatyuk S.S., Dyakova E.N., Stolyarevich E.S.
Castleman's disease associated with amyloidosis. Literature review and clinical observation
|
№2 / 2023
|
Русский
